Annual Quaterly
Annual
Quaterly
Operating Results Financial condition Cash Flows Per share data Major Indicators Segments Data Drug Fostering Program formulations "Growing"formulations Other
Operating Results Financial condition Cash Flows Segments Data Drug Fostering Program formulations "Growing"formulations Other

Operating Results

*Japanese GAAP
XLS downloads
(Unit：millions of yen)
FY2015 FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Net sales 112,625 114,954 117,879 120,906 123,248 130,883 129,546 140,043 150,845 181,093 192,615
Gross profit 67,569 65,499 68,275 71,455 72,500 74,931 66,465 68,281 68,816 90,583 91,516
Operating profit 19,826 15,983 17,050 18,520 18,876 19,382 22,376 20,916 20,017 40,125 35,219
Operating profit margin 17.6% 13.9% 14.5% 15.3% 15.3% 14.8% 17.3% 14.9% 13.3% 22.2% 18.3%
Ordinary profit 19,494 16,399 17,914 19,702 19,649 20,866 25,904 23,453 23,493 42,446 40,036
Profit before income taxes 18,898 17,184 20,284 19,897 19,223 20,456 25,563 23,018 23,736 45,559 41,036
Profit attributable to owners of parent 12,557 12,488 14,504 14,593 13,765 15,332 18,836 16,482 16,707 32,428 28,117
Disclaimer
provided by StockWeather.com,Inc.